Tanvex BioPharma, Inc. announced resignation of Peter Lin as financial officer and appointed Kevin Yeh as financial officer with effect on November 01, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
38.1 TWD | -2.31% | -11.09% | -41.47% |
1st Jan change | Capi. | |
---|---|---|
-41.47% | 194M | |
+10.79% | 116B | |
+11.65% | 106B | |
-6.20% | 23.89B | |
-2.33% | 21.58B | |
-6.03% | 18.96B | |
-13.41% | 16.33B | |
-40.50% | 16.96B | |
+6.64% | 14.14B | |
+31.84% | 12.02B |
- Stock Market
- Equities
- 6541 Stock
- News Tanvex BioPharma, Inc.
- Tanvex BioPharma, Inc. Announces Management Changes